CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 1 of 1
Non-Antibody Products
Page 1,068 of 1,288
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| RRx-001 | An anticancer agent; inhibits growth in a panel of 12 cancer cell lines (I… | 1 mg | 28846-1 | More Info |
| RRx-001 | An anticancer agent; inhibits growth in a panel of 12 cancer cell lines (I… | 10 mg | 28846-10 | More Info |
| RRx-001 | An anticancer agent; inhibits growth in a panel of 12 cancer cell lines (I… | 25 mg | 28846-25 | More Info |
| RRx-001 | An anticancer agent; inhibits growth in a panel of 12 cancer cell lines (I… | 5 mg | 28846-5 | More Info |
| RS 504393 | A selective antagonist of CCR2 (IC50s = 89 nM); inhibits MCP-1-stimulated… | 1 mg | 17330-1 | More Info |
| RS 504393 | A selective antagonist of CCR2 (IC50s = 89 nM); inhibits MCP-1-stimulated… | 10 mg | 17330-10 | More Info |
| RS 504393 | A selective antagonist of CCR2 (IC50s = 89 nM); inhibits MCP-1-stimulated… | 25 mg | 17330-25 | More Info |
| RS 504393 | A selective antagonist of CCR2 (IC50s = 89 nM); inhibits MCP-1-stimulated… | 5 mg | 17330-5 | More Info |
| RS-1 | An activator of RAD51 (Kd = 48-107 for human RAD51); a potent enhancer of… | 10 mg | 21037-10 | More Info |
| RS-1 | An activator of RAD51 (Kd = 48-107 for human RAD51); a potent enhancer of… | 25 mg | 21037-25 | More Info |
| RS-1 | An activator of RAD51 (Kd = 48-107 for human RAD51); a potent enhancer of… | 5 mg | 21037-5 | More Info |
| RS-1 | An activator of RAD51 (Kd = 48-107 for human RAD51); a potent enhancer of… | 50 mg | 21037-50 | More Info |
| (1R,3S)-3-Aminocyclopentane carboxylic acid | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11401-50 | More Info |
| (1R,3S)-3-Amino-cyclopentanol | A synthetic intermediate useful for pharmaceutical synthesis. | 10 mg | 11357-10 | More Info |
| (1R,3S)-3-Amino-cyclopentanol | A synthetic intermediate useful for pharmaceutical synthesis. | 100 mg | 11357-100 | More Info |
| (1R,3S)-3-Amino-cyclopentanol | A synthetic intermediate useful for pharmaceutical synthesis. | 250 mg | 11357-250 | More Info |
| (1R,3S)-3-Amino-cyclopentanol | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11357-50 | More Info |
| (R,S)-AMPA (hydrate) | The defining agonist for the AMPA subgroup of ionotropic glutamate recepto… | 10 mg | 14571-10 | More Info |
| (R,S)-AMPA (hydrate) | The defining agonist for the AMPA subgroup of ionotropic glutamate recepto… | 25 mg | 14571-25 | More Info |
| (R,S)-AMPA (hydrate) | The defining agonist for the AMPA subgroup of ionotropic glutamate recepto… | 5 mg | 14571-5 | More Info |
| (R,S)-AMPA (hydrate) | The defining agonist for the AMPA subgroup of ionotropic glutamate recepto… | 50 mg | 14571-50 | More Info |
| (R,S)-Anatabine | A minor tobacco alkaloid; an agonist of α4β2 and α6/&alph… | 10 mg | 11001-10 | More Info |
| (R,S)-Anatabine | A minor tobacco alkaloid; an agonist of α4β2 and α6/&alph… | 100 mg | 11001-100 | More Info |
| (R,S)-Anatabine | A minor tobacco alkaloid; an agonist of α4β2 and α6/&alph… | 5 mg | 11001-5 | More Info |
| (R,S)-Anatabine | A minor tobacco alkaloid; an agonist of α4β2 and α6/&alph… | 50 mg | 11001-50 | More Info |
| (R,S)-Anatabine-d4 | An internal standard for the quantification of (R,S)-anatabine by GC- or L… | 1 mg | 37198-1 | More Info |
| (R,S)-Anatabine (tartrate) | A minor tobacco alkaloid; an agonist of α4β2 and α6/&alph… | 10 mg | 15132-10 | More Info |
| (R,S)-Anatabine (tartrate) | A minor tobacco alkaloid; an agonist of α4β2 and α6/&alph… | 100 mg | 15132-100 | More Info |
| (R,S)-Anatabine (tartrate) | A minor tobacco alkaloid; an agonist of α4β2 and α6/&alph… | 5 mg | 15132-5 | More Info |
| (R,S)-Anatabine (tartrate) | A minor tobacco alkaloid; an agonist of α4β2 and α6/&alph… | 50 mg | 15132-50 | More Info |
| 17(R,S)-Benzo-Resolvin D1 | A derivative of resolvin D1; reduces PDGF-BB-induced cytoskeletal changes… | 10 µg | 10623-10 | More Info |
| 17(R,S)-Benzo-Resolvin D1 | A derivative of resolvin D1; reduces PDGF-BB-induced cytoskeletal changes… | 25 µg | 10623-25 | More Info |
| 17(R,S)-Benzo-Resolvin D1 | A derivative of resolvin D1; reduces PDGF-BB-induced cytoskeletal changes… | 50 µg | 10623-50 | More Info |
| (1R,9S)-(-)-β-Hydrastine | An inhibitor of dopamine biosynthesis (IC50 = 20.7 µM in PC12 cells)… | 10 mg | 22363-10 | More Info |
| (1R,9S)-(-)-β-Hydrastine | An inhibitor of dopamine biosynthesis (IC50 = 20.7 µM in PC12 cells)… | 25 mg | 22363-25 | More Info |
| (1R,9S)-(-)-β-Hydrastine | An inhibitor of dopamine biosynthesis (IC50 = 20.7 µM in PC12 cells)… | 5 mg | 22363-5 | More Info |
| (1R,9S)-(-)-β-Hydrastine | An inhibitor of dopamine biosynthesis (IC50 = 20.7 µM in PC12 cells)… | 50 mg | 22363-50 | More Info |
| (R,S)-BHFF | A positive allosteric modulator of GABAB receptors; increases the potency… | 10 mg | 25535-10 | More Info |
| (R,S)-BHFF | A positive allosteric modulator of GABAB receptors; increases the potency… | 25 mg | 25535-25 | More Info |
| (R,S)-BHFF | A positive allosteric modulator of GABAB receptors; increases the potency… | 5 mg | 25535-5 | More Info |
| (R,S)-BHFF | A positive allosteric modulator of GABAB receptors; increases the potency… | 50 mg | 25535-50 | More Info |
| RSC-133 | Promotes the reprogramming of human somatic cells to pluripotent stem cell… | 1 mg | 9001839-1 | More Info |
| RSC-133 | Promotes the reprogramming of human somatic cells to pluripotent stem cell… | 10 mg | 9001839-10 | More Info |
| RSC-133 | Promotes the reprogramming of human somatic cells to pluripotent stem cell… | 25 mg | 9001839-25 | More Info |
| RSC-133 | Promotes the reprogramming of human somatic cells to pluripotent stem cell… | 5 mg | 9001839-5 | More Info |
| (R,S)-Carvedilol Glucuronide | A racemic mixture of the carvedilol metabolites (R)-carvedilol glucuronide… | 500 µg | 27173-500 | More Info |
| (R,S)-CHPG | A potent and selective agonist at mGluR5; EC50 of 750 µM for calcium… | 10 mg | 21408-10 | More Info |
| (R,S)-CHPG | A potent and selective agonist at mGluR5; EC50 of 750 µM for calcium… | 25 mg | 21408-25 | More Info |
| (R,S)-CHPG | A potent and selective agonist at mGluR5; EC50 of 750 µM for calcium… | 5 mg | 21408-5 | More Info |
| (R,S)-CHPG | A potent and selective agonist at mGluR5; EC50 of 750 µM for calcium… | 50 mg | 21408-50 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile